WallStreetZenWallStreetZen

NYSE: RBOT
Vicarious Surgical Inc Earnings & Revenue

Open Broker Account

RBOT earnings and revenue history

Current Revenue
$0.0
Current Earnings
$38.1M
Current Profit Margin
0%

RBOT Return on Equity

Current Company
33.9%
Current Industry
8.2%
Current Market
-8.3%
RBOT's Return on Equity (33.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RBOT announces earnings.

RBOT Return on Assets

Current Company
22.5%
Current Industry
5%
RBOT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RBOT Return on Capital Employed

Current Company
27.51%
Current Industry
7.7%

RBOT vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RBOT$0.00$39.71M$38.12MN/AN/A
APEN$71.71M-$29.48M-$40.69M+2.46%N/A
OFIX$463.55M$10.22M-$45.50M+1.73%N/A
SIBN$99.69M-$58.95M-$64.56M+16.82%N/A
RXST$41.34M-$58.22M-$66.88M+116.67%N/A

Vicarious Surgical Earnings & Revenue FAQ

What were RBOT's earnings last quarter?

On Invalid Date, Vicarious Surgical (NYSE: RBOT) reported Q3 2022 earnings per share (EPS) of -$0.20, up 59.18% year over year. Total Vicarious Surgical earnings for the quarter were -$24.74 million. In the same quarter last year, Vicarious Surgical's earnings per share (EPS) was -$0.49.

If you're new to stock investing, here's how to buy Vicarious Surgical stock.

What was RBOT's earnings growth in the past year?

As of Q4 2022, Vicarious Surgical's earnings has grown year over year. Vicarious Surgical's earnings in the past year totalled $38.12 million.

What was RBOT's revenue last quarter?

On Invalid Date, Vicarious Surgical (NYSE: RBOT) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Vicarious Surgical's revenue was $0.00.

What was RBOT's revenue growth in the past year?

As of Q4 2022, Vicarious Surgical's revenue has grown null year over year. Vicarious Surgical's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.